DAY 1Structural heart diseaseValvular Aortic valve

SOLACI CACI 2017 | When and how to interving patients with CAD undergoing TAVI

solaci
solaci
503
0
Dr. Fabio Sandoli
Dr. Fabio Sandoli

Read articles on the main presentations of the first day of SOLACI-CACI 2017 Congress.

See the presentation by Dr. Fabio Sandoli, entitled “When and how to interving patients with CAD undergoing TAVI”.

de-Brito-Jr-Fbio-Sandoli

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Previous article
SOLACI CACI 2017 | How did Europe transform the treatment of STEMI patients?
Next article
SOLACI CACI 2017 | New horizons in percutaneous mitral valve implantation
solaci
solaci

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Dr. Juan Manuel Pérez - 0
Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Dr. Juan Manuel Pérez - 0
Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Structural heart disease

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

Dr. Juan Manuel Pérez - 0
The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

Dr. Omar Tupayachi - 0
The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Dr. Juan Manuel Pérez - 0
Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...